What exactly is adalimumab? what is it used for

Adalimumab (Adalimumab) is a biologic drug that belongs to the class of anti-tumor necrosis factor (TNF)-α monoclonal antibody drugs. It reduces inflammation and immune system overactivity by specifically binding to tumor necrosis factor alpha (TNF-alpha) and blocking its effects. TNF-α is a cytokine that plays an important role in immune responses, especially in autoimmune diseases and inflammatory responses. By inhibiting TNF-α, adalimumab can slow down the progression of inflammation-related diseases and help control the disease.

Adalimumab has a wide range of uses and is mainly used to treat a variety of inflammatory diseases caused by abnormal activation of the immune system. It is clinically approved for the treatment of rheumatoid arthritis (RA), psoriasis, active psoriatic arthritis(PA), atopic dermatitis (AD),ulcerative colitis, Crohn's disease (CD), ankylosing spondylitis and other diseases. A common feature of these diseases is that the immune system mistakenly attacks healthy tissue, leading to chronic inflammation and tissue damage. Adalimumab helps improve patients' symptoms, reduce pain, and improve joint and skin function by reducing inflammation levels in the body.

For rheumatoid arthritis, adalimumab has been shown to be effective in slowing joint damage and relieving pain and stiffness in patients. For ankylosing spondylitis, it can help improve the range of motion of the spine, reduce inflammation and relieve pain. The broad availability of adalimumab makes it an important treatment option for many patients in the management of inflammatory diseases.

In short, adalimumab, as an antiTNF-α monoclonal antibody, can effectively treat a variety of autoimmune diseases by regulating the function of the immune system. Its application has provided new treatment options for many patients and significantly improved their quality of life.

Reference materials:https://www.drugs.com/adalimumab.html